Practice Management Conference - Virtual Meeting (2018)
Due to continuous legislative, regulatory and coding changes practice managers and urologists lack the knowledge required to implement changes to their practice.
Target Audience
This activity is designed for:
- Urologists
- Practice Managers
- Advanced Practice Providers
Learning Objectives
After completing this activity, participants will be able to:
1. Improve your practice's ability to adapt to changing business strategies
2. Develop tools to assist with efficient practice operations
3. Cultivate patient and referral source loyalty
4. Optimize revenue from patient services
5. Exchange ideas with peers about the latest urology management hot topics.
Day One
7:00-8:00am Registration & Continental Breakfast with Exhibitors
8:00-9:30am Maintaining Independence as a Practice………………………… Max Reiboldt
9:30-10:30am Moving from Volume to Value – Determining The Cost of Care…………………. Neil Baum, MD
10:30-11:30am Urology Coding - Coding Challenges for 2018……………………………………………. Edna Maldonado
11:30am-12:00 Exhibit Break
12:00-1:30pm Luncheon
1:30-2:20pm Session # 1 - Choose 1 of the following 4 sessions
Masters Track– Principals of Patient Engagement and Satisfaction …… Ellis Knight, MD
Financial Track– Nuts & Bolts of Effective Practice Operations……… Jay Motola, MD
Physician Track- How to Best On-Board your Physician...............Nicole Jenkins
Management Track- Utilizing Benchmarking for your Practice……… John O’Connor
2:30-3:20pm Session # 2 - Choose 1 of the following 4 sessions
Masters Track– USP800 Regulation –What you Need to Know…….… Dan Schonwald
Financial Track– Effective Financial Operations for your Practice........... Jeff Gorke
Physician Track- Best Practices for Contract Negotiations.... Max Reiboldt
Management Track– Improve Practice Management through Participating in AQUA Registry… Matthew Cooperberg MD,
Steve Schlossberg MD, Ronald Suh MD, Felice Washington
3:30-4:00pm Exhibit Break
4:00-5:30pm Information and Technology Lightning Rounds
Short Discussions about Several Important Topics..................... Jeffery Daigrepont
Round 1- Beyond EHRs – (Future IT Trends, Gadgets, Predictions and Speculation)
Round 2- ePatient Communications (How to Securely Communicate with Patients)
Round 3- Vendor Contracting (Strategies for Negotiating New Contacts and Existing Ones)
Round 4- Key System Requirements to Support Value Based Reimbursement
5:30-6:15pm Networking Reception
Day Two
7:00-8:00am Registration & Continental Breakfast with Exhibitors
8:00-9:00am Government and Regulatory Update............................. Thomas Rechtschaffen, MD
9:00-10:00am MACRA Update – What your Practice Needs to Know………. Franklin Gaylis, MD
10:00-11:00am Effective Integration of APP’s in Urology……Brooke Zilinskas PA, Tricia Zubert NP, Jody Purifoy NP, Anne
Calvaresi CRNP
11:00-11:30am Exhibit Break
11:30-12:30pm Luncheon
Current Hot Topic Discussion-Join fellow attendees in a live forum to discuss the matters that are impacting
your practice. Whether you’re from a solo practice, a medium or large- sized urology group, or even a hospital
or academic practice, there’s a discussion group to meet your needs.
12:30-1:20pm Choose 1 of the following 4 sessions
Hospital / Academic Owned Practices
Independent Small Urology Practices (1-5 Providers)
Independent Medium Urology Practices (6-19 Providers)
Independent Large Urology Practices (20+ Providers)
1:30-2:20pm Choose 1 of the following 4 sessions
Hospital / Academic Owned Practices
Independent Small Urology Practices (1-5 Providers)
Independent Medium Urology Practices (6-19 Providers)
Independent Large Urology Practices (20+ Providers)
2:30-4:00pm Building and Maintaining Risk Management and Compliance Programs for your Organization ………. Sean Weiss
Faculty and Disclosures
Planner Disclosures:
- Victor Nitti, MD - Serenity Pharmaceuticals Self Yes Investment Interest 01/09/2012 Present
- Brant Inman, MD - Combat Medical Self Yes Consultant or Advisor 02/01/2016 Present
Speaker Disclosures
- Neil Baum, MD – Meeting participant or lecturer with Coloplast, Watson, Eli Lilly, Ferring – Consultant with NeoTract, and Reel Health Network.
- Matthew Cooperberg – Consultant with Dendreon, Myriad Genetics, MDx Health, and Astellas – Meeting participant or lecturer with GenomeDx.
- Jeffrey Daigrepont – Meeting participant or lecturer with The Coker Group.
- Franklin Gaylis, MD – Owner, Product Development of GenIT LLC – Scientific Study or Trial with Astellas, Janssen Pharmaceuticals, and Bayer Pharmaceuticals – Consultant with Specialty Networks LLC.
- Ellis Knight, MD – Employee with Coker Group.
- Jay Motola, MD – Investment Interest with Allied Urological/Metropolitan Lithotripsy – Consultant and Meeting participant or lecturer with Healthtronics.
- Thomas Rechtschaffen, MD – Meeting Participant or lecturer with Astellas Pharmaceuticals US.
- Max Reiboldt – Leadership position, consultant, and employee with The Coker Group.
- Daniel Schonwald – Consultant with Vital Source GPO, Dendreon, and Integra Connect.
- Ronald Suh – Owner of Surgical Data Solutions, LLC – Scientific study or trial with Ferring Pharmaceuticals, Atellas, Bayer Pharmaceuticals, and Medivation/Pfizer – Meeting participant or lecturer with Endo Pharmaceutical.
- Brooke Zilinskas, PA – Leadership position and meeting participant or lecturer with Urology Association of Physician Assistant
The following individuals had no disclosures to report:
- Anne Calvaresi, CRNP
- Rebecca Durham
- Jeff Gorke
- Nicole Jenkins
- Edna Maldonado, CPC
- Jody Purifoy, DNP, APRN, CNP
- Steven Schlossberg
- Sean Weiss
- Tricia Zubert, NP
There is no CME for this product.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.